Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer.
Junjia LiuXuefeng WangIbrahim H SahinIman ImaniradSeth I FelderRichard D KimHao XiePublished in: American journal of clinical oncology (2022)
Tumor response-speed heterogeneity to first-line chemotherapy was a novel prognostic factor associated with early disease progression and shorter survival in patients with metastatic colorectal cancer.